Link
Reframing Obesity in Psoriatic Disease: From Pharmacokinetic Barrier to Therapeutic Target.
In this article, IPC Board Member Lluís Puig, MD, PhD, gives his expert commentary on two randomized trials showing…
In this article, IPC Board Member Lluís Puig, MD, PhD, gives his expert commentary on two randomized trials showing…
View MoreThis commentary from IPC Board Member Lluís Puig examines inference-based guidance for managing immune checkpoint…
View MoreThis commentary from IPC Board Member Lluís Puig examines inference-based guidance for managing immune checkpoint…
Read MoreThe International Psoriasis Council (IPC) and the National Psoriasis Foundation (NPC) have released a joint position…
View ReportThe 33rd Annual EADV Congress in Amsterdam featured updates on psoriasis care, including highlights from the IPC…
Read MoreGeneralized pustular psoriasis(GPP)lacks internationally accepted definitions and diagnostic criteria, impeding timely…
View ReportThis commentary provides expert analysis on recent research findings, clinical trial results, and the promising future…
Read MoreDr. Lluís Puig examines the evolving treatment landscape for psoriasis and discusses various treatment and therapy…
Watch VideoROMANIAN ASSOCIATION OF DERMATOLOGY & VENEREOLOGY (ARDV) ANNUAL CONGRESS | BUCHAREST, ROMANIA Friday, November…
ACADEMIA ESPAÑOLA DE DERMATOLOGÍA Y VENEREOLOGÍA (AEDV) CONGRESS | MADRID, SPAIN Thursday, January 18 18:00 -…
This is the second webinar of the IPC Global Webinar Series. It focuses on psoriasis and cancer or chronic infections.
Watch VideoIPC GLOBAL WEBINAR SERIES April 18 3:30 pm - 4:30 pm CEST 9:30 am - 10:30 am EDT Program chair: Lluís Puig,…
The European Academy of Dermatology and Venereology (EADV) organized its 31st congress in Milano, Italy, under the…
Read MoreEUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (EADV) | BERLIN, GERMANY Wednesday, October 11 8:30 – 11:45 am…
In the final webinar in the series, we will explore lessons from the SARS-CoV-2 pandemic and how we can prepare for…
Watch VideoThe European Academy of Dermatology and Venerelogy 30th Annual Congress (EADV) was packed with science and clinical…
Read MoreThomas Sharnitz, MD, has written the report, summarizing the most important presentations with a focus on psoriasis…
View ReportView Report
Dr. Lluís Puig provides his comments on a recent publication on the classification of the cutaneous manifestations of…
Read More| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
IPC Jr. Councilor Towhida Noor reviews the psoriasis pipeline: selective TYK2 inhibitors, long-acting IL-17 and IL-23 biologics, and IL-36 blockade in GPP.
IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.
PRE-ORDER YOUR COPY
In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.
IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.